We found that cholecalciferol supplementation significantly reduced serum levels of Ang-2, as also shown in a recent study that reported a reduction in circulating levels of VEGF-A and Ang-2 in breast cancer patients after treatment with cholecalciferol supplementation [17]. This evidence concerns the gene ANGPT2 and breast carcinoma.